In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Grunenthal GmbH

http://www.grunenthal.com

Latest From Grunenthal GmbH

Grünenthal Bolsters US Portfolio With Buyout Of Valinor

Deal snapshot: The German pain-management specialist is acquiring Valinor to gain additional geographic rights to the gastrointestinal drug Movantik and add to its US product portfolio.

M & A Business Strategies

Breaking The Pain Market’s Addiction To Opioids

The recent success of Vertex in acute pain merely highlights the agonizingly slow process elsewhere, particularly in chronic pain indications.

Neurology Clinical Trials

US FDA’s Breakthrough Designation Pace Slows, But Topics Broaden

The 19 breakthrough therapy designations awarded so far this year run the gamut from areas that traditionally have not fared well with BTDs, like cardiovascular and respiratory disease, alongside the traditional cancer and orphan disease tentpoles.

US FDA Performance Tracker Review Pathway

Finance Watch: Biopharma Stocks Attempt An April Rebound

Public Company Edition: With the XBI up more than 9% in April, a few follow-on offerings –$23m to support Gamida Cell’s small product launch and $500m to fund Vaxcyte’s large clinical trial program – have made it to market. Also, China’s CytoMed launched the sixth biopharma IPO in the US this year.

Financing Business Strategies
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Adhesys Medical GmbH
    • Adhesys Medical Inc.
    • Averitas Pharma, Inc.
    • Grunenthal GmbH
    • Gruenenthal GmbH
    • Grunental GmbH
    • Inversiones Gruchi S.A.
    • Inversiones Gruchi Limitada
    • Laboratorios Andrómaco S.A.
    • Laboratoires Grunenthal SAS
    • Mestex AG
    • Thar Pharmaceuticals, Inc.
UsernamePublicRestriction

Register